Telomere Length and Checkpoint Kinase Expression Patterns Across Cytogenetic Risk Groups in Chronic Lymphocytic Leukemia
Kinases and Phosphatases · 02.04.2026 · 4 (2) · 9
DOI: 10.3390/kinasesphosphatases4020009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kinases and Phosphatases, online erschienen am 02.04.2026. Verfasst von Fábio Morato de Oliveira und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic lymphocytic leukemia (CLL) exhibits marked clinical heterogeneity that is closely associated with genomic instability. Although cytogenetic abnormalities are widely used for risk stratification, they do not fully capture the biological complexity of the disease. Telomere dysfunction and alterations in DNA damage response pathways have been implicated in disease progression, but their relationship with cytogenetic risk in CLL remains incompletely characterized. In this study, peripheral blood mononuclear cells (PBMCs) from 48 CLL patients were analyzed. The analyzed PBMC fractions were enriched in leukemic B cells, with an estimated median tumor content above 85–90%. Cytogenetic profiles were obtained by conventional karyotyping following in vitro immunostimulation with DSP30 and interleukin-2 and classified according to ERIC and Döhner criteria. Telomere length was assessed by quantitative PCR, and CHEK1 and CHEK2 expression levels were quantified by RT–qPCR. Molecular parameters were compared across cytogenetic risk groups. Distinct molecular profiles were observed across cytogenetic categories. Favorable-risk CLL cases showed preserved telomere length, low CHEK1 expression, and maintained CHEK2 levels. Intermediate-risk cases, predominantly characterized by trisomy 12, exhibited moderate telomere shortening accompanied by increased CHEK1 expression and partial reduction of CHEK2. High-risk CLL cases, defined by del(11q), del(17p), or complex karyotypes, displayed pronounced telomere shortening, marked CHEK1 upregulation, and strong suppression of CHEK2. Telomere length was inversely correlated with cytogenetic risk (Spearman’s ρ = −0.68, p < 0.0001), and the CHEK1/CHEK2 expression ratio increased progressively with genomic complexity. These findings indicate that telomere length and CHEK1/CHEK2 expression patterns are closely associated with cytogenetic risk in CLL and may provide complementary biological information for risk stratification.
Zitieren
APA
Oliveira, F. M. D., Neto, F. S. L., Fernandes, E. V., Bocchi, M., & Ferreira, B. M. R. (2026). Telomere Length and Checkpoint Kinase Expression Patterns Across Cytogenetic Risk Groups in Chronic Lymphocytic Leukemia. Kinases and Phosphatases, 4(2), 9. https://doi.org/10.3390/kinasesphosphatases4020009
Vancouver
Oliveira FMD, Neto FSL, Fernandes EV, Bocchi M, Ferreira BMR. Telomere Length and Checkpoint Kinase Expression Patterns Across Cytogenetic Risk Groups in Chronic Lymphocytic Leukemia. Kinases and Phosphatases. 2026;4(2):9. doi:10.3390/kinasesphosphatases4020009
BibTeX
@article{Oliveira2026,
author = {Oliveira, Fábio Morato de and Neto, Fermino Sanches Lizarte and Fernandes, Eduardo Vignoto and Bocchi, Mayara and Ferreira, Bruno Machado Rezende},
title = {Telomere Length and Checkpoint Kinase Expression Patterns Across Cytogenetic Risk Groups in Chronic Lymphocytic Leukemia},
journal = {Kinases and Phosphatases},
year = {2026},
volume = {4},
number = {2},
pages = {9},
doi = {10.3390/kinasesphosphatases4020009}
}
EUVIMED